STRATEGY STUDIO / NONPROFIT PEOPLE SEARCH

OKLAHOMA MEDICAL RESEARCH FOUNDATION: Form 990, tax year 2021

View the entire original 990 at ProPublica ↗

Organization
OKLAHOMA MEDICAL RESEARCH FOUNDATION (EIN 73-0580274)
Tax period
2021-07-01 to 2022-06-30
Filed
2023-05-13
IRS object ID
202311329349309581
Schema version
2021v4.2
Source
Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header ReturnHeader

FieldValueIRS element (for citing)
Return2023-05-13T02:30:18+00:00ReturnTs
Tax Period End2022-06-30TaxPeriodEndDt
Return Type990ReturnTypeCd
Tax Period Begin2021-07-01TaxPeriodBeginDt

Filer Filer

FieldValueIRS element (for citing)
EIN730580274EIN

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1Oklahoma Medical Research FoundationBusinessNameLine1Txt
FieldValueIRS element (for citing)
Business Name ControlOKLABusinessNameControlTxt
Phone4052717421PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line1825 NE 13th StreetAddressLine1Txt
CityOklahoma CityCityNm
State AbbreviationOKStateAbbreviationCd
ZIP73104ZIPCd

Business Officer BusinessOfficerGrp

FieldValueIRS element (for citing)
PersonTim HassenPersonNm
Person TitleVP and Chief Financial OfficerPersonTitleTxt
Phone4052717421PhoneNum
Signature2023-05-13SignatureDt

Signing Officer SigningOfficerGrp

Person Full Name PersonFullName

FieldValueIRS element (for citing)
Person FirstTimPersonFirstNm
Person LastHassenPersonLastNm
FieldValueIRS element (for citing)
SSN999009999SSN
FieldValueIRS element (for citing)
Tax2021TaxYr
Build TS2023-04-26 12:10:37ZBuildTS

Form 990 IRS990

Principal Ofcr Business Name PrincipalOfcrBusinessName

FieldValueIRS element (for citing)
Business Name Line1Tim Hassen VP and CFOBusinessNameLine1Txt

US Address USAddress

FieldValueIRS element (for citing)
Address Line1825 NE 13th StreetAddressLine1Txt
CityOklahoma CityCityNm
State AbbreviationOKStateAbbreviationCd
ZIP73104ZIPCd
FieldValueIRS element (for citing)
Gross Receipts$171,272,531GrossReceiptsAmt
Group Return For AffiliatesfalseGroupReturnForAffiliatesInd
Organization501c3Yes (X)Organization501c3Ind
Website Addresswww.omrf.orgWebsiteAddressTxt
Type Of Organization CorpYes (X)TypeOfOrganizationCorpInd
Formation1946FormationYr
Legal Domicile StateOKLegalDomicileStateCd
Activity Or MissionOklahoma Medical Research Foundation (OMRF) is dedicated to developing a better understanding of and more effective treatments for human disease.ActivityOrMissionDesc
Voting Members Governing Body62VotingMembersGoverningBodyCnt
Voting Members Independent62VotingMembersIndependentCnt
Total Employee624TotalEmployeeCnt
Total Volunteers62TotalVolunteersCnt
Total Gross UBI$52,456TotalGrossUBIAmt
Net Unrelated Bus Txbl Incm$46,210NetUnrelatedBusTxblIncmAmt
PY Contributions Grants$91,435,276PYContributionsGrantsAmt
CY Contributions Grants$70,293,950CYContributionsGrantsAmt
PY Program Service Revenue$24,073,794PYProgramServiceRevenueAmt
CY Program Service Revenue$25,749,144CYProgramServiceRevenueAmt
PY Investment Income$4,418,313PYInvestmentIncomeAmt
CY Investment Income$4,449,737CYInvestmentIncomeAmt
PY Other Revenue$6,089,431PYOtherRevenueAmt
CY Other Revenue$7,252,044CYOtherRevenueAmt
PY Total Revenue$126,016,814PYTotalRevenueAmt
CY Total Revenue$107,744,875CYTotalRevenueAmt
CY Grants And Similar Paid$0CYGrantsAndSimilarPaidAmt
CY Benefits Paid To Members$0CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid$40,750,886PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid$43,028,876CYSalariesCompEmpBnftPaidAmt
CY Total Prof Fndrsng Expns$0CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense$1,515,122CYTotalFundraisingExpenseAmt
PY Other Expenses$51,587,701PYOtherExpensesAmt
CY Other Expenses$53,911,297CYOtherExpensesAmt
PY Total Expenses$92,338,587PYTotalExpensesAmt
CY Total Expenses$96,940,173CYTotalExpensesAmt
PY Revenues Less Expenses$33,678,227PYRevenuesLessExpensesAmt
CY Revenues Less Expenses$10,804,702CYRevenuesLessExpensesAmt
Total Assets BOY$499,810,540TotalAssetsBOYAmt
Total Assets EOY$463,812,009TotalAssetsEOYAmt
Total Liabilities BOY$37,672,357TotalLiabilitiesBOYAmt
Total Liabilities EOY$33,583,504TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY$462,138,183NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY$430,228,505NetAssetsOrFundBalancesEOYAmt
Info In Schedule O Part IIIYes (X)InfoInScheduleOPartIIIInd
MissionOMRF is dedicated to developing a better understanding of more effective treatments for human disease.MissionDesc
Significant New Program SrvcfalseSignificantNewProgramSrvcInd
Significant ChangefalseSignificantChangeInd
Expense$35,742,508ExpenseAmt
Grant$0GrantAmt
Revenue$19,896,272RevenueAmt
DescArthritis & Clinical Immunology/Clinical Operations - The National Institutes of Health selected OMRF to lead a newly funded Accelerating Medicines Partnership in Autoimmune and Immune-Mediated Diseases initiative. This nationwide consortium is focused on understanding and developing new treatments for lupus, rheumatoid arthritis and other diseases of autoimmunity. Dr. Judith James serves as the national principal investigator for this network, which includes more than 40 research institutions, five NIH institutes and centers, and partners from industry and patient organizations. In October, Dr. James was elected to the National Academy of Medicine, one of the field's highest honors.Desc

Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp

FieldValueIRS element (for citing)
Expense$7,186,146ExpenseAmt
Grant$0GrantAmt
Revenue$8,297,233RevenueAmt
DescCardiovascular Biology Research Program - Work in this program cast new light on the development of a poorly understood organ called the omentum. Scientists also made new insights that could lead to advances in wound healing and more effective treatment strategies for diabetes and sepsis, which is the leading killer in U.S. intensive care units. Finally, Dr. Lijun Xia found that an experimental drug being tested to treat a rare blood disorder may also benefit people who have sickle cell disease. "In our previous work, we looked at one therapeutic work for vaso-occlusive crises," says OMRF's Dr. Rod McEver, whose discoveries led to the first treatment for the pain crises that accompany the condition. "Dr. Xia is looking at another, and this provides a strong basis for a clinical trial."Desc

Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp

FieldValueIRS element (for citing)
Expense$7,162,295ExpenseAmt
Grant$0GrantAmt
Revenue$8,602,803RevenueAmt
DescAging and Metabolism Research Program - Scientists in this program made a range of discoveries in 2022, from identifying traits in ovarian cancer cells that could improve chemotherapy treatments to insights that may slow the aging in the heart. On the technology front, they invented a new method to manipulate genetic coding and made key contributions to a patent application for a drug that could treat post-injury osteoarthritis pain. In addition, Dr. Benjamin Miller discovered that cells in muscle can replicate DNA. This counters 40 years of textbook knowledge and opens up an alternative to stem cell therapy, which has largely proven unsuccessful as a treatment for damaged muscles.Desc

Prog Srvc Accom Acty Other ProgSrvcAccomActyOtherGrp

FieldValueIRS element (for citing)
Expense$40,777,358ExpenseAmt
Grant$0GrantAmt
Revenue$30,570,204RevenueAmt
DescOther program services include departments such as Cell Cycle and Cancer Biology, Genes and Human Disease, Genetic Models of Disease and other scientific and research support services.Desc
FieldValueIRS element (for citing)
Total Other Prog Srvc Expense$40,777,358TotalOtherProgSrvcExpenseAmt
Total Other Prog Srvc Revenue$30,570,204TotalOtherProgSrvcRevenueAmt
Total Program Service Expenses$90,868,307TotalProgramServiceExpensesAmt
Described In Section501c3Yes (true)DescribedInSection501c3Ind
Schedule B RequiredYes (true)ScheduleBRequiredInd
Political Campaign ActyfalsePoliticalCampaignActyInd
Lobbying ActivitiesYes (true)LobbyingActivitiesInd
Donor Advised FundfalseDonorAdvisedFundInd
Conservation EasementsfalseConservationEasementsInd
Collections Of ArtfalseCollectionsOfArtInd
Credit CounselingfalseCreditCounselingInd
Donor Rstr Or Quasi EndowmentsYes (true)DonorRstrOrQuasiEndowmentsInd
Report Land Building EquipmentYes (true)ReportLandBuildingEquipmentInd
Report Investments Other SecYes (true)ReportInvestmentsOtherSecInd
Report Program Related InvstfalseReportProgramRelatedInvstInd
Report Other AssetsYes (true)ReportOtherAssetsInd
Report Other LiabilitiesYes (true)ReportOtherLiabilitiesInd
Include FIN48 FootnoteYes (true)IncludeFIN48FootnoteInd
Independent Audit Fincl StmtYes (true)IndependentAuditFinclStmtInd
Consolidated Audit Fincl StmtYes (true)ConsolidatedAuditFinclStmtInd
School OperatingfalseSchoolOperatingInd
Foreign OfficefalseForeignOfficeInd
Foreign ActivitiesYes (true)ForeignActivitiesInd
More Than5000 K To OrgfalseMoreThan5000KToOrgInd
More Than5000 K To IndividualsfalseMoreThan5000KToIndividualsInd
Professional FundraisingfalseProfessionalFundraisingInd
Fundraising ActivitiesfalseFundraisingActivitiesInd
Gaming ActivitiesfalseGamingActivitiesInd
Operate HospitalfalseOperateHospitalInd
Grants To OrganizationsfalseGrantsToOrganizationsInd
Grants To IndividualsfalseGrantsToIndividualsInd
Schedule J RequiredYes (true)ScheduleJRequiredInd
Tax Exempt BondsYes (true)TaxExemptBondsInd
Invest Tax Exempt BondsfalseInvestTaxExemptBondsInd
Escrow AccountfalseEscrowAccountInd
On Behalf Of IssuerfalseOnBehalfOfIssuerInd
Engaged In Excess Benefit TransfalseEngagedInExcessBenefitTransInd
PY Excess Benefit TransfalsePYExcessBenefitTransInd
Loan OutstandingfalseLoanOutstandingInd
Grant To Related PersonfalseGrantToRelatedPersonInd
Business Rln With Org MemfalseBusinessRlnWithOrgMemInd
Business Rln With Fam MemfalseBusinessRlnWithFamMemInd
Business Rln With35 Ctrl EntfalseBusinessRlnWith35CtrlEntInd
Deductible Non Cash ContriYes (true)DeductibleNonCashContriInd
Deductible Art ContributionfalseDeductibleArtContributionInd
Terminate OperationsfalseTerminateOperationsInd
Partial LiquidationfalsePartialLiquidationInd
Disregarded EntityYes (true)DisregardedEntityInd
Related EntityfalseRelatedEntityInd
Related Organization Ctrl EntfalseRelatedOrganizationCtrlEntInd
Trnsfr Exmpt Non Chrtbl Rltd OrgfalseTrnsfrExmptNonChrtblRltdOrgInd
Activities Conducted PrtshpfalseActivitiesConductedPrtshpInd
Schedule O RequiredYes (true)ScheduleORequiredInd
IRP Document134IRPDocumentCnt
IRP Document W2 G0IRPDocumentW2GCnt
Backup Wthld ComplianceYes (true)BackupWthldComplianceInd
Employee624EmployeeCnt
Employment Tax Returns FiledYes (true)EmploymentTaxReturnsFiledInd
Unrelated Bus Incm Over LimitYes (true)UnrelatedBusIncmOverLimitInd
Form990 T FiledYes (true)Form990TFiledInd
Foreign Financial AccountfalseForeignFinancialAccountInd
Prohibited Tax Shelter TransfalseProhibitedTaxShelterTransInd
Taxable Party NotificationfalseTaxablePartyNotificationInd
Nondeductible ContributionsYes (true)NondeductibleContributionsInd
Nondeductible Contri DisclYes (true)NondeductibleContriDisclInd
Quid Pro Quo ContributionsYes (true)QuidProQuoContributionsInd
Quid Pro Quo Contri DisclYes (true)QuidProQuoContriDisclInd
Form8282 Property Disposed OffalseForm8282PropertyDisposedOfInd
Rcv Fnds To Pay Prsnl Bnft CntrctfalseRcvFndsToPayPrsnlBnftCntrctInd
Pay Premiums Prsnl Bnft CntrctfalsePayPremiumsPrsnlBnftCntrctInd
Form8899 FiledindtrueForm8899Filedind
Form1098 C FiledYes (true)Form1098CFiledInd
Indoor Tanning ServicesfalseIndoorTanningServicesInd
Subj To Tax Rmnrtn Ex Prcht PymtfalseSubjToTaxRmnrtnExPrchtPymtInd
Subject To Excs Tax Net Invst IncfalseSubjectToExcsTaxNetInvstIncInd
Info In Schedule O Part VIYes (X)InfoInScheduleOPartVIInd
Governing Body Voting Members62GoverningBodyVotingMembersCnt
Independent Voting Member62IndependentVotingMemberCnt
Family Or Business RlnfalseFamilyOrBusinessRlnInd
Delegation Of Mgmt DutiesfalseDelegationOfMgmtDutiesInd
Change To Org DocumentsfalseChangeToOrgDocumentsInd
Material Diversion Or MisusefalseMaterialDiversionOrMisuseInd
Members Or StockholdersfalseMembersOrStockholdersInd
Election Of Board MembersfalseElectionOfBoardMembersInd
Decisions Subject To ApprovafalseDecisionsSubjectToApprovaInd
Minutes Of Governing BodyYes (true)MinutesOfGoverningBodyInd
Minutes Of CommitteesYes (true)MinutesOfCommitteesInd
Officer Mailing AddressfalseOfficerMailingAddressInd
Local ChaptersfalseLocalChaptersInd
Form990 Provided To Gvrn BodyYes (true)Form990ProvidedToGvrnBodyInd
Conflict Of Interest PolicyYes (true)ConflictOfInterestPolicyInd
Annual Disclosure Covered PrsnYes (true)AnnualDisclosureCoveredPrsnInd
Regular Monitoring EnfrcYes (true)RegularMonitoringEnfrcInd
Whistleblower PolicyYes (true)WhistleblowerPolicyInd
Document Retention PolicyYes (true)DocumentRetentionPolicyInd
Compensation Process CEOYes (true)CompensationProcessCEOInd
Compensation Process OtherYes (true)CompensationProcessOtherInd
Investment In Joint VenturefalseInvestmentInJointVentureInd
States Where Copy Of Return Is FldOKStatesWhereCopyOfReturnIsFldCd
Upon RequestYes (X)UponRequestInd
OtherYes (X)OtherInd

Books In Care Of Detail BooksInCareOfDetail

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1Tim Hassen VP and Chief Financial OfficerBusinessNameLine1Txt
FieldValueIRS element (for citing)
Phone4052717421PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line1825 NE 13th StreetAddressLine1Txt
CityOklahoma CityCityNm
State AbbreviationOKStateAbbreviationCd
ZIP73104ZIPCd

Form990 Part VII Section A Form990PartVIISectionAGrp (78 entries)

TitleTitleTxtAverage Hours Per WeekAverageHoursPerWeekRtIndividual Trustee Or DirectorIndividualTrusteeOrDirectorIndReportable Comp From OrgReportableCompFromOrgAmtReportable Comp From Rltd OrgReportableCompFromRltdOrgAmtOther CompensationOtherCompensationAmtOfficerOfficerIndKey EmployeeKeyEmployeeIndHighest Compensated EmployeeHighestCompensatedEmployeeInd
Albers Leigh Ann
Board Member1.0Yes (X)$0$0$0
Anoatubby Bill
Board Member1.0Yes (X)$0$0$0
Bell Sharon
Board Member1.0Yes (X)$0$0$0
Benbrook Bruce
Board Member1.0Yes (X)$0$0$0
Benham Lance
Board Member1.0Yes (X)$0$0$0
Boghetich JII
Board Member1.0Yes (X)$0$0$0
Braught Barbara
Board Member1.0Yes (X)$0$0$0
Brown Randy
Board Member1.0Yes (X)$0$0$0
Burgess Ellen
Board Member1.0Yes (X)$0$0$0
Carolina Mike
Board Member1.0Yes (X)$0$0$0
Cason Len
Board Member1.0Yes (X)$0$0$0
Cawley Michael
Board Member1.0Yes (X)$0$0$0
Champlin Hiram
Board Member1.0Yes (X)$0$0$0
Collins Mark
Board Member1.0Yes (X)$0$0$0
Drake Ramsey
Board Member1.0Yes (X)$0$0$0
Duncan Walt
Board Member1.0Yes (X)$0$0$0
Eagan Claire
Board Member1.0Yes (X)$0$0$0
Edwards Carl
Board Member1.0Yes (X)$0$0$0
Everest Christy
Board Member1.0Yes (X)$0$0$0
Everest Tricia
Board Member1.0Yes (X)$0$0$0
Felton Ann
Board Member1.0Yes (X)$0$0$0
Funke Mark
Board Member1.0Yes (X)$0$0$0
Gamble Gerald
Board Member1.0Yes (X)$0$0$0
Griffin John
Board Member1.0Yes (X)$0$0$0
Groendyke Virginia
Board Member1.0Yes (X)$0$0$0
Haglund Jacqui
Board Member1.0Yes (X)$0$0$0
Hall Brooks
Board Member1.0Yes (X)$0$0$0
Hargis Burns
Board Member1.0Yes (X)$0$0$0
Hatfield Judy
Board Member1.0Yes (X)$0$0$0
Hawley Bill
Board Member1.0Yes (X)$0$0$0
Henry Kim
Board Member1.0Yes (X)$0$0$0
Hogan Randy
Board Member1.0Yes (X)$0$0$0
Holmes Jerome
Board Member1.0Yes (X)$0$0$0
Hudson Cliff
Board Member1.0Yes (X)$0$0$0
Irani Ronnie
Board Member1.0Yes (X)$0$0$0
Jameson Brett
Board Member1.0Yes (X)$0$0$0
Johnstone Bill
Board Member1.0Yes (X)$0$0$0
Kern Terence
Board Member1.0Yes (X)$0$0$0
Kerr Lou
Board Member1.0Yes (X)$0$0$0
Levy Harrison
Board Member1.0Yes (X)$0$0$0
Little Dan
Board Member1.0Yes (X)$0$0$0
Loughridge Bill
Board Member1.0Yes (X)$0$0$0
Mahaney Mindy
Board Member1.0Yes (X)$0$0$0
McCarty Jack
Board Member1.0Yes (X)$0$0$0
Morris Jim
Board Member1.0Yes (X)$0$0$0
Nichols Larry
Board Member1.0Yes (X)$0$0$0
Parry Richard
Board Member1.0Yes (X)$0$0$0
Patten Rebecca
Board Member1.0Yes (X)$0$0$0
Payne Bond
Board Member1.0Yes (X)$0$0$0
Pollard Barry
Board Member1.0Yes (X)$0$0$0
Rainbolt David
Board Member1.0Yes (X)$0$0$0
Replogle Dee
Board Member1.0Yes (X)$0$0$0
Rooney Pat
Board Member1.0Yes (X)$0$0$0
Saxon John
Board Member1.0Yes (X)$0$0$0
Schulte Paul
Board Member1.0Yes (X)$0$0$0
Swimmer Ross
Board Member1.0Yes (X)$0$0$0
Switzer Becky
Board Member1.0Yes (X)$0$0$0
Taylor Steven
Board Member1.0Yes (X)$0$0$0
Thorpe Betsy
Board Member1.0Yes (X)$0$0$0
Walton Greg
Board Member1.0Yes (X)$0$0$0
Williams G Rainey Jr
Board Member1.0Yes (X)$0$0$0
Yauk Sarah
Board Member1.0Yes (X)$0$0$0
Cohen Adam
Sr VP and General Counsel50.0$287,752$0$58,292Yes (X)
Day Lisa
VP of Government Affairs50.0$154,452$0$24,007Yes (X)
Greenwood Courtney
VP of Human Resources50.0$184,887$0$42,771Yes (X)
Hassen Tim
VP and CFO50.0$265,733$0$63,573Yes (X)
James Judith
VP of Clinical Affairs and Program Chair50.0$462,461$0$101,753Yes (X)
McEver Rodger MD
VP of Research50.0$335,895$0$44,519Yes (X)
Prescott Stephen MD
President and CEO50.0$467,241$0$5,975Yes (X)
Voss Penny
VP of Development50.0$230,920$0$61,483Yes (X)
Gaffney Patrick MD
Program Chair, Genes and Human Disease50.0$301,532$0$60,794Yes (X)
Pardo Gabriel MD
Associate Member, Arthritis and Clinical Immunology50.0$341,368$0$51,360Yes (X)
Xia Lijun MD
Program Chair, Cardiovascular Biology50.0$292,348$0$73,415Yes (X)
Chelsea Berkley MD
Clinical Assistant Member, Arthritis and Clinical Immunology50.0$268,209$0$33,006Yes (X)
Joan Merrill MD
Member, Arthritis and Clinical Immunology50.0$259,456$0$27,753Yes (X)
Lupu Florea PhD
Member, Cardiovascular Biology50.0$297,091$0$39,149Yes (X)
Nath Swapan PhD
Member, Arthritis and Clinical Immunology50.0$294,438$0$52,000Yes (X)
Rezaie Alireza PhD
Member, Cardiovascular Biology50.0$271,613$0$43,089Yes (X)
FieldValueIRS element (for citing)
Total Reportable Comp From Org$4,715,396TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org$0TotReportableCompRltdOrgAmt
Total Other Compensation$782,939TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K67IndivRcvdGreaterThan100KCnt
Former Ofcr Employees ListedfalseFormerOfcrEmployeesListedInd
Total Comp Greater Than150 KYes (true)TotalCompGreaterThan150KInd
Compensation From Other SrcsfalseCompensationFromOtherSrcsInd

Contractor Compensation ContractorCompensationGrp (4 entries)

Address Line1ContractorAddress/USAddress/AddressLine1TxtAddress Line2ContractorAddress/USAddress/AddressLine2TxtCityContractorAddress/USAddress/CityNmState AbbreviationContractorAddress/USAddress/StateAbbreviationCdZIPContractorAddress/USAddress/ZIPCdServicesServicesDescCompensationCompensationAmt
Infusion Management LLC
11233 Shadow Creek PwkySuite 303PearlandTX77584Medical Billing Services$19,219,230
Aramark
24863 Network PlChicagoIL606731248HouseKeeping Services$562,854
CapTrust Partners LLC
6305 Waterford Blvd120Oklahoma CityOK73118Investment Management Services$108,409
Grant Thornton LLP
211 N RobinsonSuite 1200Oklahoma CityOK73102Audit services$103,500
FieldValueIRS element (for citing)
Cntrct Rcvd Greater Than100 K4CntrctRcvdGreaterThan100KCnt
Federated Campaigns$98,677FederatedCampaignsAmt
Government Grants$41,151,587GovernmentGrantsAmt
All Other Contributions$29,043,686AllOtherContributionsAmt
Noncash Contributions$771,465NoncashContributionsAmt
Total Contributions$70,293,950TotalContributionsAmt

Program Service Revenue ProgramServiceRevenueGrp

FieldValueIRS element (for citing)
DescClinic RevenueDesc
Business621990BusinessCd
Total Revenue Column$25,749,144TotalRevenueColumnAmt
Related Or Exempt Func Income$25,749,144RelatedOrExemptFuncIncomeAmt

Total Oth Program Service Rev TotalOthProgramServiceRevGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt
Related Or Exempt Func Income$0RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$0UnrelatedBusinessRevenueAmt
Exclusion$0ExclusionAmt
FieldValueIRS element (for citing)
Total Program Service Revenue$25,749,144TotalProgramServiceRevenueAmt

Investment Income InvestmentIncomeGrp

FieldValueIRS element (for citing)
Total Revenue Column$13,047,467TotalRevenueColumnAmt
Unrelated Business Revenue-$600UnrelatedBusinessRevenueAmt
Exclusion$13,048,067ExclusionAmt

Incm From Invest Bond Proceeds IncmFromInvestBondProceedsGrp

FieldValueIRS element (for citing)
Total Revenue Column$824TotalRevenueColumnAmt
Exclusion$824ExclusionAmt

Royalties Revenue RoyaltiesRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$5,060,755TotalRevenueColumnAmt
Related Or Exempt Func Income$3,325,397RelatedOrExemptFuncIncomeAmt
Exclusion$1,735,358ExclusionAmt

Gross Rents GrossRentsGrp

FieldValueIRS element (for citing)
Real$435,604RealAmt

Rental Income Or Loss RentalIncomeOrLossGrp

FieldValueIRS element (for citing)
Real$435,604RealAmt
Personal$0PersonalAmt

Net Rental Income Or Loss NetRentalIncomeOrLossGrp

FieldValueIRS element (for citing)
Total Revenue Column$435,604TotalRevenueColumnAmt
Exclusion$435,604ExclusionAmt

Gross Amount Sales Assets GrossAmountSalesAssetsGrp

FieldValueIRS element (for citing)
Securities$54,902,209SecuritiesAmt
Other$26,893OtherAmt

Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp

FieldValueIRS element (for citing)
Securities$63,143,768SecuritiesAmt
Other$383,888OtherAmt

Gain Or Loss GainOrLossGrp

FieldValueIRS element (for citing)
Securities-$8,241,559SecuritiesAmt
Other-$356,995OtherAmt

Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp

FieldValueIRS element (for citing)
Total Revenue Column-$8,598,554TotalRevenueColumnAmt
Unrelated Business Revenue$53,056UnrelatedBusinessRevenueAmt
Exclusion-$8,651,610ExclusionAmt

Other Revenue Misc OtherRevenueMiscGrp (2 entries)

DescDescBusinessBusinessCdTotal Revenue ColumnTotalRevenueColumnAmtRelated Or Exempt Func IncomeRelatedOrExemptFuncIncomeAmtExclusionExclusionAmt
Laboratory Income621500$1,495,665$1,495,665
Cafe Income722514$260,020$260,020

Miscellaneous Revenue MiscellaneousRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt
Related Or Exempt Func Income$0RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$0UnrelatedBusinessRevenueAmt
Exclusion$0ExclusionAmt
FieldValueIRS element (for citing)
Other Revenue Total$1,755,685OtherRevenueTotalAmt

Total Revenue TotalRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$107,744,875TotalRevenueColumnAmt
Related Or Exempt Func Income$30,570,206RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$52,456UnrelatedBusinessRevenueAmt
Exclusion$6,828,263ExclusionAmt

Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp

FieldValueIRS element (for citing)
Total$3,324,588TotalAmt
Program Services$2,733,578ProgramServicesAmt
Management And General$360,090ManagementAndGeneralAmt
Fundraising$230,920FundraisingAmt

Other Salaries And Wages OtherSalariesAndWagesGrp

FieldValueIRS element (for citing)
Total$29,828,654TotalAmt
Program Services$27,937,938ProgramServicesAmt
Management And General$1,205,913ManagementAndGeneralAmt
Fundraising$684,803FundraisingAmt

Pension Plan Contributions PensionPlanContributionsGrp

FieldValueIRS element (for citing)
Total$2,407,769TotalAmt
Program Services$2,227,532ProgramServicesAmt
Management And General$113,732ManagementAndGeneralAmt
Fundraising$66,505FundraisingAmt

Other Employee Benefits OtherEmployeeBenefitsGrp

FieldValueIRS element (for citing)
Total$5,241,878TotalAmt
Program Services$4,702,194ProgramServicesAmt
Management And General$409,987ManagementAndGeneralAmt
Fundraising$129,697FundraisingAmt

Payroll Taxes PayrollTaxesGrp

FieldValueIRS element (for citing)
Total$2,225,987TotalAmt
Program Services$2,059,358ProgramServicesAmt
Management And General$105,145ManagementAndGeneralAmt
Fundraising$61,484FundraisingAmt

Fees For Services Legal FeesForServicesLegalGrp

FieldValueIRS element (for citing)
Total$123,601TotalAmt
Program Services$90,876ProgramServicesAmt
Management And General$32,725ManagementAndGeneralAmt

Fees For Services Accounting FeesForServicesAccountingGrp

FieldValueIRS element (for citing)
Total$128,500TotalAmt
Management And General$128,500ManagementAndGeneralAmt

Fees For Services Lobbying FeesForServicesLobbyingGrp

FieldValueIRS element (for citing)
Total$61,398TotalAmt
Management And General$61,398ManagementAndGeneralAmt

Fees For Services Other FeesForServicesOtherGrp

FieldValueIRS element (for citing)
Total$2,222,504TotalAmt
Program Services$2,222,504ProgramServicesAmt
Management And General$0ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Office Expenses OfficeExpensesGrp

FieldValueIRS element (for citing)
Total$552,032TotalAmt
Program Services$315,970ProgramServicesAmt
Management And General$70,928ManagementAndGeneralAmt
Fundraising$165,134FundraisingAmt

Information Technology InformationTechnologyGrp

FieldValueIRS element (for citing)
Total$1,234,019TotalAmt
Program Services$1,022,472ProgramServicesAmt
Management And General$154,425ManagementAndGeneralAmt
Fundraising$57,122FundraisingAmt

Occupancy OccupancyGrp

FieldValueIRS element (for citing)
Total$4,402,737TotalAmt
Program Services$3,554,454ProgramServicesAmt
Management And General$847,881ManagementAndGeneralAmt
Fundraising$402FundraisingAmt

Travel TravelGrp

FieldValueIRS element (for citing)
Total$433,868TotalAmt
Program Services$392,088ProgramServicesAmt
Management And General$36,269ManagementAndGeneralAmt
Fundraising$5,511FundraisingAmt

Conferences Meetings ConferencesMeetingsGrp

FieldValueIRS element (for citing)
Total$57,020TotalAmt
Program Services$57,020ProgramServicesAmt

Interest InterestGrp

FieldValueIRS element (for citing)
Total$291,945TotalAmt
Program Services$281,730ProgramServicesAmt
Management And General$10,215ManagementAndGeneralAmt

Depreciation Depletion DepreciationDepletionGrp

FieldValueIRS element (for citing)
Total$7,831,079TotalAmt
Program Services$7,508,788ProgramServicesAmt
Management And General$322,291ManagementAndGeneralAmt

Insurance InsuranceGrp

FieldValueIRS element (for citing)
Total$460,574TotalAmt
Program Services$338,632ProgramServicesAmt
Management And General$121,942ManagementAndGeneralAmt

Other Expenses OtherExpensesGrp (4 entries)

DescDescTotalTotalAmtProgram ServicesProgramServicesAmtManagement And GeneralManagementAndGeneralAmtFundraisingFundraisingAmt
Lab supplies$6,783,936$6,783,936
Trainee costs$1,005,251$1,005,251
Inhouse$1,943,748$1,921,891$12,680$9,177
Subcontracts$23,769,976$23,769,976

All Other Expenses AllOtherExpensesGrp

FieldValueIRS element (for citing)
Total$2,609,109TotalAmt
Program Services$1,942,121ProgramServicesAmt
Management And General$562,621ManagementAndGeneralAmt
Fundraising$104,367FundraisingAmt

Total Functional Expenses TotalFunctionalExpensesGrp

FieldValueIRS element (for citing)
Total$96,940,173TotalAmt
Program Services$90,868,309ProgramServicesAmt
Management And General$4,556,742ManagementAndGeneralAmt
Fundraising$1,515,122FundraisingAmt

Cash Non Interest Bearing CashNonInterestBearingGrp

FieldValueIRS element (for citing)
BOY$3,640BOYAmt
EOY$3,640EOYAmt

Savings And Temp Cash Invst SavingsAndTempCashInvstGrp

FieldValueIRS element (for citing)
BOY$13,461,294BOYAmt
EOY$16,213,977EOYAmt

Pledges And Grants Receivable PledgesAndGrantsReceivableGrp

FieldValueIRS element (for citing)
BOY$12,076,179BOYAmt
EOY$10,570,230EOYAmt

Accounts Receivable AccountsReceivableGrp

FieldValueIRS element (for citing)
BOY$7,010,620BOYAmt
EOY$7,702,655EOYAmt

Receivables From Officers Etc ReceivablesFromOfficersEtcGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Rcvbl From Disqualified Prsn RcvblFromDisqualifiedPrsnGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Oth Notes Loans Receivable Net OthNotesLoansReceivableNetGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$54,328EOYAmt

Inventories For Sale Or Use InventoriesForSaleOrUseGrp

FieldValueIRS element (for citing)
BOY$11,361BOYAmt
EOY$10,789EOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

FieldValueIRS element (for citing)
BOY$596,373BOYAmt
EOY$596,913EOYAmt
FieldValueIRS element (for citing)
Land Bldg Equip Cost Or Other Bss$244,372,789LandBldgEquipCostOrOtherBssAmt
Land Bldg Equip Accum Deprec$157,604,559LandBldgEquipAccumDeprecAmt

Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp

FieldValueIRS element (for citing)
BOY$91,167,104BOYAmt
EOY$86,768,230EOYAmt

Investments Pub Traded Sec InvestmentsPubTradedSecGrp

FieldValueIRS element (for citing)
BOY$153,961,065BOYAmt
EOY$141,958,646EOYAmt

Investments Other Securities InvestmentsOtherSecuritiesGrp

FieldValueIRS element (for citing)
BOY$27,928,033BOYAmt
EOY$28,051,204EOYAmt

Investments Program Related InvestmentsProgramRelatedGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt

Other Assets Total OtherAssetsTotalGrp

FieldValueIRS element (for citing)
BOY$193,594,871BOYAmt
EOY$171,881,397EOYAmt

Total Assets TotalAssetsGrp

FieldValueIRS element (for citing)
BOY$499,810,540BOYAmt
EOY$463,812,009EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

FieldValueIRS element (for citing)
BOY$10,463,099BOYAmt
EOY$10,104,927EOYAmt

Deferred Revenue DeferredRevenueGrp

FieldValueIRS element (for citing)
BOY$1,350,878BOYAmt
EOY$2,315,779EOYAmt

Tax Exempt Bond Liabilities TaxExemptBondLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$16,885,000BOYAmt
EOY$13,935,000EOYAmt

Loans From Officers Directors LoansFromOfficersDirectorsGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Other Liabilities OtherLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$8,973,380BOYAmt
EOY$7,227,798EOYAmt

Total Liabilities TotalLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$37,672,357BOYAmt
EOY$33,583,504EOYAmt
FieldValueIRS element (for citing)
Organization Follows FASB117Yes (X)OrganizationFollowsFASB117Ind

No Donor Restriction Net Assets NoDonorRestrictionNetAssetsGrp

FieldValueIRS element (for citing)
BOY$146,514,111BOYAmt
EOY$152,426,452EOYAmt

Donor Restriction Net Assets DonorRestrictionNetAssetsGrp

FieldValueIRS element (for citing)
BOY$315,624,072BOYAmt
EOY$277,802,053EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$462,138,183BOYAmt
EOY$430,228,505EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$499,810,540BOYAmt
EOY$463,812,009EOYAmt
FieldValueIRS element (for citing)
Info In Schedule O Part XIYes (X)InfoInScheduleOPartXIInd
Reconcilation Revenue Expnss$10,804,702ReconcilationRevenueExpnssAmt
Net Unrlzd Gains Losses Invst-$25,053,993NetUnrlzdGainsLossesInvstAmt
Other Changes In Net Assets-$17,660,387OtherChangesInNetAssetsAmt
Method Of Accounting AccrualYes (X)MethodOfAccountingAccrualInd
Accountant Compile Or ReviewfalseAccountantCompileOrReviewInd
FS AuditedYes (true)FSAuditedInd

FS Audited Basis FSAuditedBasisGrp

FieldValueIRS element (for citing)
Consolidated Basis Fincl StmtYes (X)ConsolidatedBasisFinclStmtInd
FieldValueIRS element (for citing)
Audit CommitteeYes (true)AuditCommitteeInd
Federal Grant Audit RequiredYes (true)FederalGrantAuditRequiredInd
Federal Grant Audit PerformedYes (true)FederalGrantAuditPerformedInd

Schedule A IRS990ScheduleA

FieldValueIRS element (for citing)
Public Organization170Yes (X)PublicOrganization170Ind

Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$58,406,493CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$60,132,921CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$60,164,768CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$91,435,276CurrentTaxYearMinus1YearAmt
Current Tax Year$70,293,950CurrentTaxYearAmt
Total$340,433,408TotalAmt

Tax Rev Levied Orgnztnl Bnft170 TaxRevLeviedOrgnztnlBnft170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$0CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$0CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$0CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$0CurrentTaxYearMinus1YearAmt
Current Tax Year$0CurrentTaxYearAmt
Total$0TotalAmt

Govt Furn Srvc Fclts Vl170 GovtFurnSrvcFcltsVl170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$0CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$0CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$0CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$0CurrentTaxYearMinus1YearAmt
Current Tax Year$0CurrentTaxYearAmt
Total$0TotalAmt

Total Calendar Year170 TotalCalendarYear170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$58,406,493CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$60,132,921CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$60,164,768CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$91,435,276CurrentTaxYearMinus1YearAmt
Current Tax Year$70,293,950CurrentTaxYearAmt
Total$340,433,408TotalAmt
FieldValueIRS element (for citing)
Substantial Contributors Tot$40,291,514SubstantialContributorsTotAmt
Public Support Total170$300,141,894PublicSupportTotal170Amt

Gross Investment Income170 GrossInvestmentIncome170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$8,549,189CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$13,563,861CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$3,495,987CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$8,109,982CurrentTaxYearMinus1YearAmt
Current Tax Year$15,219,254CurrentTaxYearAmt
Total$48,938,273TotalAmt

Unrelated Business Net Incm170 UnrelatedBusinessNetIncm170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$5,304CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$81,073CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$5,337CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$10,725CurrentTaxYearMinus1YearAmt
Current Tax Year$51,456CurrentTaxYearAmt
Total$153,895TotalAmt

Other Income170 OtherIncome170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$334,103CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$347,212CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$295,959CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$158,503CurrentTaxYearMinus1YearAmt
Current Tax Year$260,020CurrentTaxYearAmt
Total$1,395,797TotalAmt
FieldValueIRS element (for citing)
Total Support$390,921,373TotalSupportAmt
Gross Receipts Rltd Activities$144,043,319GrossReceiptsRltdActivitiesAmt
Public Support CY1700.7678PublicSupportCY170Pct
Public Support PY1700.7468PublicSupportPY170Pct
Thirty Thr Pct Suprt Tests CY170Yes (X)ThirtyThrPctSuprtTestsCY170Ind

Form990 Schedule A Part VI Form990ScheduleAPartVIGrp (2 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
Schedule A, Part II, Line 10 Schedule A, Part II, Line 10Other income includes cafeteria sales as well as fundraising income that was not included in contributions.
Schedule A, Part II, Line 10 Other IncomeDESCRIPTION - , COLUMN A - 334103.0, COLUMN B - 347212.0, COLUMN C - 295959.0, COLUMN D - 158503.0, COLUMN E - 260020.0, COLUMN F - 1395797.0;

Schedule B IRS990ScheduleB

Contributor Information ContributorInformationGrp

FieldValueIRS element (for citing)
ContributorRESTRICTEDContributorNum

Contributor Business Name ContributorBusinessName

FieldValueIRS element (for citing)
Business Name Line1RESTRICTEDBusinessNameLine1

Contributor US Address ContributorUSAddress

FieldValueIRS element (for citing)
Address Line1RESTRICTEDAddressLine1
Address Line2RESTRICTEDAddressLine2
CityRESTRICTEDCity
StateRESTRICTEDState
ZIP CodeRESTRICTEDZIPCode
FieldValueIRS element (for citing)
Total ContributionsRESTRICTEDTotalContributionsAmt

Schedule C IRS990ScheduleC

FieldValueIRS element (for citing)
VolunteersfalseVolunteersInd
Paid Staff Or ManagementYes (true)PaidStaffOrManagementInd
Media AdvertisementsfalseMediaAdvertisementsInd
Mailings MembersfalseMailingsMembersInd
Publications Or BroadcastfalsePublicationsOrBroadcastInd
Grants Other OrganizationsfalseGrantsOtherOrganizationsInd
Direct Contact LegislatorsYes (true)DirectContactLegislatorsInd
Direct Contact Legislators$349,456DirectContactLegislatorsAmt
Rallies DemonstrationsfalseRalliesDemonstrationsInd
Other ActivitiesfalseOtherActivitiesInd
Total Lobbying Expenditures$349,456TotalLobbyingExpendituresAmt
Not Described Section501c3falseNotDescribedSection501c3Ind

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferenceSchedule C, Part II-B, Line 1 DETAILED DESCRIPTION OF THE LOBBYING ACTIVITYFormAndLineReferenceDesc
ExplanationThe Foundation's lobbying activities entail monitoring proposed legislation and educating legislators and their staffs about the Foundation, medical research and the impact of proposed legislation on medical research and the Foundation.ExplanationTxt

Schedule D IRS990ScheduleD

CY Endwmt Fund CYEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$169,632,776BeginningYearBalanceAmt
Contributions$12,453,227ContributionsAmt
Investment Earnings Or Losses-$18,843,658InvestmentEarningsOrLossesAmt
Other Expenditures$5,200,000OtherExpendituresAmt
End Year Balance$158,042,345EndYearBalanceAmt

CY Minus1 Yr Endwmt Fund CYMinus1YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$116,281,093BeginningYearBalanceAmt
Contributions$18,987,421ContributionsAmt
Investment Earnings Or Losses$39,164,262InvestmentEarningsOrLossesAmt
Grants Or Scholarships$0GrantsOrScholarshipsAmt
Other Expenditures$4,800,000OtherExpendituresAmt
Administrative Expenses$0AdministrativeExpensesAmt
End Year Balance$169,632,776EndYearBalanceAmt

CY Minus2 Yr Endwmt Fund CYMinus2YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$115,938,978BeginningYearBalanceAmt
Contributions$26,722ContributionsAmt
Investment Earnings Or Losses$4,715,393InvestmentEarningsOrLossesAmt
Grants Or Scholarships$0GrantsOrScholarshipsAmt
Other Expenditures$4,400,000OtherExpendituresAmt
Administrative Expenses$0AdministrativeExpensesAmt
End Year Balance$116,281,093EndYearBalanceAmt

CY Minus3 Yr Endwmt Fund CYMinus3YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$97,512,842BeginningYearBalanceAmt
Contributions$16,719,850ContributionsAmt
Investment Earnings Or Losses$5,906,286InvestmentEarningsOrLossesAmt
Grants Or Scholarships$0GrantsOrScholarshipsAmt
Other Expenditures$4,200,000OtherExpendituresAmt
Administrative Expenses$0AdministrativeExpensesAmt
End Year Balance$115,938,978EndYearBalanceAmt

CY Minus4 Yr Endwmt Fund CYMinus4YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$91,545,136BeginningYearBalanceAmt
Contributions$75,342ContributionsAmt
Investment Earnings Or Losses$9,892,364InvestmentEarningsOrLossesAmt
Grants Or Scholarships$0GrantsOrScholarshipsAmt
Other Expenditures$4,000,000OtherExpendituresAmt
Administrative Expenses$0AdministrativeExpensesAmt
End Year Balance$97,512,842EndYearBalanceAmt
FieldValueIRS element (for citing)
Board Designated Balance EOY0.3369BoardDesignatedBalanceEOYPct
Prmnnt Endowment Balance EOY0.3834PrmnntEndowmentBalanceEOYPct
Term Endowment Balance EOY0.2797TermEndowmentBalanceEOYPct
Endowments Held Unrelated OrgYes (true)EndowmentsHeldUnrelatedOrgInd
Endowments Held Related OrgfalseEndowmentsHeldRelatedOrgInd

Land LandGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$4,080,847OtherCostOrOtherBasisAmt
Book Value$4,080,847BookValueAmt

Buildings BuildingsGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$186,381,018OtherCostOrOtherBasisAmt
Depreciation$117,400,249DepreciationAmt
Book Value$68,980,769BookValueAmt

Equipment EquipmentGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$53,876,066OtherCostOrOtherBasisAmt
Depreciation$40,204,310DepreciationAmt
Book Value$13,671,756BookValueAmt

Other Land Buildings OtherLandBuildingsGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$34,858OtherCostOrOtherBasisAmt
Book Value$34,858BookValueAmt
FieldValueIRS element (for citing)
Total Book Value Land Buildings$86,768,230TotalBookValueLandBuildingsAmt

Other Securities OtherSecuritiesGrp

FieldValueIRS element (for citing)
DescOther securitesDesc
Book Value$28,051,204BookValueAmt
Method ValuationFMethodValuationCd
FieldValueIRS element (for citing)
Total Book Value Securities$28,051,204TotalBookValueSecuritiesAmt

Other Assets Org OtherAssetsOrgGrp (8 entries)

DescDescBook ValueBookValueAmt
Funds held in trust by others$143,791,326
Wills and Bequests$22,307,665
Cash Surrender Value of Life Insurance$5,388,177
Debt Issue Costs$106,470
Deposits$211,823
Accrued Interest Receivable$27,850
Assets Held for Sale$47,970
Minerals$116
FieldValueIRS element (for citing)
Total Book Value Other Assets$171,881,397TotalBookValueOtherAssetsAmt

Other Liabilities Org OtherLiabilitiesOrgGrp (2 entries)

DescDescAmtAmt
Postretirement Benefits and Deferred Comp$7,112,861
Split Interest Agreements$114,937
FieldValueIRS element (for citing)
Total Liability$7,227,798TotalLiabilityAmt
Footnote TextYes (X)FootnoteTextInd
Total Rev Etc Audited Fincl Stmt$65,030,495TotalRevEtcAuditedFinclStmtAmt
Net Unrealized Gains Invst-$25,053,993NetUnrealizedGainsInvstAmt
Other Revenue-$17,660,387OtherRevenueAmt
Revenue Not Reported-$42,714,380RevenueNotReportedAmt
Revenue Subtotal$107,744,875RevenueSubtotalAmt
Other Revenues Not Included$0OtherRevenuesNotIncludedAmt
Revenue Not Reported Fincl Stmt$0RevenueNotReportedFinclStmtAmt
Total Revenue Per Form990$107,744,875TotalRevenuePerForm990Amt
Tot Expns Etc Audited Fincl Stmt$96,940,173TotExpnsEtcAuditedFinclStmtAmt
Other Expenses Included$0OtherExpensesIncludedAmt
Expenses Not Reported$0ExpensesNotReportedAmt
Expenses Subtotal$96,940,173ExpensesSubtotalAmt
Other Expenses Not Included$0OtherExpensesNotIncludedAmt
Expenses Not Rpt Fincl Stmt$0ExpensesNotRptFinclStmtAmt
Total Expenses Per Form990$96,940,173TotalExpensesPerForm990Amt

Supplemental Information Detail SupplementalInformationDetail (3 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
Schedule D, Part V, Line 4 Intended uses of endowment fundsThe Foundation's endowment consists of individual funds established to provide the Foundation with funding in perpetuity.
Schedule D, Part X, Line 2 FIN 48 (ASC 740) footnoteThe Foundation is a public foundation exempt from federal income tax under section 501(c)(3) of the internal revenue code except for amounts relating to unrelated business income. There were no known material unrelated business income taxes incurred in 2022 and accordingly, no provision for income taxes has been made in these financial statements. Management has reviewed the Foundation's tax position and concluded that there are no uncertain tax positions that require accrual in the consolidated financial statements or disclosure in the footnotes to be in compliance with authoritative literature. Generally, the Foundation is no longer subject to income tax examination by federal, state or local tax authorities for years prior to 2019. The statute of limitations will remain open for both federal and state purposes for any returns not filed.
Schedule D, Part XI, Line 2(d) Other revenues in audited financial statements not in form 990CHANGES IN FAIR VALUE OF FUNDS HELD IN TRUST - -19063515 PENSION RELATED CHANGES OTHER THAN NET PERIODIC PENSION COSTS - 1403128

Schedule F IRS990ScheduleF

Account Activities Outside US AccountActivitiesOutsideUSGrp (5 entries)

RegionRegionTxtOfficesOfficesCntEmployeeEmployeeCntType Of Activities ConductedTypeOfActivitiesConductedTxtRegion Total ExpendituresRegionTotalExpendituresAmtSpecific Services ProvidedSpecificServicesProvidedTxt
Europe (Including Iceland and Greenland)06Conference Travel$17,684
Europe (Including Iceland and Greenland)013Program Services$14,750Student Program
North America (Canada & Mexico only)06Conference Travel$13,880
North America (Canada & Mexico only)00Investments$161,210
Central America and the Caribbean00Investments$1,286,744
FieldValueIRS element (for citing)
Subtotal Offices0SubtotalOfficesCnt
Subtotal Employees25SubtotalEmployeesCnt
Continuation Total Office0ContinuationTotalOfficeCnt
Continuation Total Employee0ContinuationTotalEmployeeCnt
Total Office0TotalOfficeCnt
Total Employee25TotalEmployeeCnt
Subtotal Spent$1,494,268SubtotalSpentAmt
Continuation Spent$0ContinuationSpentAmt
Total Spent$1,494,268TotalSpentAmt
Transfer To Foreign CorpYes (true)TransferToForeignCorpInd
Interest In Foreign TrustfalseInterestInForeignTrustInd
Foreign Corp OwnershipfalseForeignCorpOwnershipInd
Passive Foreign Investmest CofalsePassiveForeignInvestmestCoInd
Foreign PartnershipYes (true)ForeignPartnershipInd
Boycott CountriesfalseBoycottCountriesInd

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferenceSchedule F, Part I, Line 3 Method used to account for expenditures on org's financial statementsFormAndLineReferenceDesc
ExplanationCENTRAL AMERICA AND THE CARIBBEAN-Accrual; EUROPE (INCLUDING ICELAND AND GREENLAND)-Accrual; NORTH AMERICA (CANADA & MEXICO ONLY)-AccrualExplanationTxt

Schedule J IRS990ScheduleJ

FieldValueIRS element (for citing)
First Class Or Charter TravelYes (X)FirstClassOrCharterTravelInd
Travel For CompanionsYes (X)TravelForCompanionsInd
Written Policy Ref T And E ExpnssYes (true)WrittenPolicyRefTAndEExpnssInd
Substantiation RequiredYes (true)SubstantiationRequiredInd
Compensation CommitteeYes (X)CompensationCommitteeInd
Independent ConsultantYes (X)IndependentConsultantInd
Form990 Of Other OrganizationsYes (X)Form990OfOtherOrganizationsInd
Compensation SurveyYes (X)CompensationSurveyInd
Board Or Committee ApprovalYes (X)BoardOrCommitteeApprovalInd
Severance PaymentfalseSeverancePaymentInd
Supplemental Nonqual Rtr PlanYes (true)SupplementalNonqualRtrPlanInd
Equity Based Comp ArrngmfalseEquityBasedCompArrngmInd
Comp Based On Revenue Of Flng OrgfalseCompBasedOnRevenueOfFlngOrgInd
Comp Bsd On Rev Related OrgsfalseCompBsdOnRevRelatedOrgsInd
Comp Bsd Net Earns Flng OrgfalseCompBsdNetEarnsFlngOrgInd
Comp Bsd Net Earns Rltd OrgsfalseCompBsdNetEarnsRltdOrgsInd
Any Non Fixed PaymentsYes (true)AnyNonFixedPaymentsInd
Initial Contract ExceptionfalseInitialContractExceptionInd

Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (16 entries)

TitleTitleTxtBase Compensation Filing OrgBaseCompensationFilingOrgAmtCompensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmtBonus Filing OrganizationBonusFilingOrganizationAmountBonus Related OrganizationsBonusRelatedOrganizationsAmtOther Compensation Filing OrgOtherCompensationFilingOrgAmtOther Compensation Rltd OrgsOtherCompensationRltdOrgsAmtDeferred Compensation Flng OrgDeferredCompensationFlngOrgAmtDeferred Comp Rltd OrgsDeferredCompRltdOrgsAmtNontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmtNontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmtTotal Compensation Filing OrgTotalCompensationFilingOrgAmtTotal Compensation Rltd OrgsTotalCompensationRltdOrgsAmtComp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmtComp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt
Prescott Stephen MD
President and CEO$351,938$0$95,000$0$20,303$0$0$0$5,975$0$473,216$0$0$0
Cohen Adam
Sr VP and General Counsel$265,460$0$0$0$22,292$0$45,386$0$12,906$0$346,044$0$0$0
Voss Penny
VP of Development$209,408$0$0$0$21,512$0$48,253$0$13,230$0$292,403$0$0$0
Hassen Tim
VP and CFO$238,071$0$150$0$27,512$0$42,943$0$20,630$0$329,306$0$0$0
Day Lisa
VP of Government Affairs$150,794$0$0$0$3,658$0$12,851$0$11,156$0$178,459$0$0$0
Greenwood Courtney
VP of Human Resources$179,487$0$0$0$5,400$0$22,449$0$20,322$0$227,658$0$0$0
James Judith
VP of Clinical Affairs and Program Chair$414,849$0$0$0$47,612$0$89,957$0$11,796$0$564,214$0$0$0
McEver Rodger MD
VP of Research$287,861$0$0$0$48,034$0$31,587$0$12,932$0$380,414$0$0$0
Pardo Gabriel MD
Associate Member, Arthritis and Clinical Immunology$338,096$0$0$0$3,272$0$31,590$0$19,770$0$392,728$0$0$0
Gaffney Patrick MD
Program Chair, Genes and Human Disease$286,260$0$0$0$15,272$0$41,024$0$19,770$0$362,326$0$0$0
Xia Lijun MD
Program Chair, Cardiovascular Biology$234,116$0$10,000$0$48,232$0$57,609$0$15,806$0$365,763$0$0$0
Nath Swapan PhD
Member, Arthritis and Clinical Immunology$252,856$0$150$0$41,432$0$31,590$0$20,410$0$346,438$0$0$0
Lupu Florea PhD
Member, Cardiovascular Biology$274,796$0$0$0$22,295$0$31,590$0$7,559$0$336,240$0$0$0
Rezaie Alireza PhD
Member, Cardiovascular Biology$223,718$0$0$0$47,895$0$29,517$0$13,572$0$314,702$0$0$0
Joan Merrill MD
Member, Arthritis and Clinical Immunology$229,175$0$7,000$0$23,281$0$26,401$0$1,352$0$287,209$0$0$0
Chelsea Berkley MD
Clinical Assistant Member, Arthritis and Clinical Immunology$247,337$0$20,000$0$872$0$26,401$0$6,605$0$301,215$0$0$0

Supplemental Information Detail SupplementalInformationDetail (5 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
Schedule J, Part I, Line 1a First-class or charter travelFirst class travel is allowed for the CEO to allow him to accomplish work related to tasks while traveling.
Schedule J, Part I, Line 1a Travel for companionsTravel for companions is allowed in certain limited circumstances where the companion's presence has a benefit to the Foundation but does not qualify as a business expense under IRS rules. In those limited cases the companion's travel expenses are treated as taxable compensation.
Schedule J, Part I, Line 4b Supplemental nonqualified retirement planThe Board of the Foundation periodically uses non-qualified retirement plans as a retention tool. The amount reported is the amount vested in the 457(f) plan. The remaining amount of the plan is not vested and is subject to substantial risk of forfeiture.
Schedule J, Part I, Line 7 Non-fixed paymentsThe CEO receives an annual bonus that is determined by leadership of the board of directors based on performance. The bonus is considered as a portion of total compensation and is subject to the review process previously described.
Schedule J, Part I, Line 3Compensation for the CEO is determined by leadership of the board of directors based on comparability data from widely accepted peer benchmarking surveys that are segmented by region and size of entity.

Schedule K IRS990ScheduleK

Tax Exempt Bonds Issues TaxExemptBondsIssuesGrp

FieldValueIRS element (for citing)
Bond ReferenceABondReferenceCd

Issuer Name IssuerName

FieldValueIRS element (for citing)
Business Name Line1Oklahoma Industries Authority Revenue Bonds (OMRF Project) Series 2016BusinessNameLine1Txt
FieldValueIRS element (for citing)
Bond Issuer EIN736194355BondIssuerEIN
CUSIP000000000CUSIPNum
Bond Issued2016-07-13BondIssuedDt
Issue Price$29,535,000IssuePriceAmt
PurposeRefunding of prior year 2008 bondPurposeDesc
DefeasedfalseDefeasedInd
On Behalf Of IssuerfalseOnBehalfOfIssuerInd
Pool FinancingfalsePoolFinancingInd

Tax Exempt Bonds Proceeds TaxExemptBondsProceedsGrp

FieldValueIRS element (for citing)
Bond ReferenceABondReferenceCd
Retired$15,600,000RetiredAmt
Bond Defeased$0BondDefeasedAmt
Total Proceeds$29,535,000TotalProceedsAmt
In Reserve Fund$2,953,564InReserveFundAmt
Capitalized Interest$0CapitalizedInterestAmt
Refunding Escrow$26,315,325RefundingEscrowAmt
Issuance Costs From Proceeds$266,175IssuanceCostsFromProceedsAmt
Credit Enhancement$0CreditEnhancementAmt
Working Capital Expenditures$0WorkingCapitalExpendituresAmt
Capital Expenditures$0CapitalExpendituresAmt
Other Spent Proceeds$0OtherSpentProceedsAmt
Unspent$0UnspentAmt
Substantial Completion2016SubstantialCompletionYr
Refunding Tax Exempt BondsfalseRefundingTaxExemptBondsInd
Refunding Taxable BondsYes (true)RefundingTaxableBondsInd
Final Allocation MadeYes (true)FinalAllocationMadeInd
Adequate Books And Rec MaintYes (true)AdequateBooksAndRecMaintInd

Tax Exempt Bonds Private Bus Use TaxExemptBondsPrivateBusUseGrp

FieldValueIRS element (for citing)
Bond ReferenceABondReferenceCd
Owning Bond Financed PropertyfalseOwningBondFinancedPropertyInd
Any Lease ArrangementsfalseAnyLeaseArrangementsInd
Mgmt Contract Bond Fincd PropfalseMgmtContractBondFincdPropInd
Any Research AgreementsYes (true)AnyResearchAgreementsInd
Engage Bond Counsel ResearchYes (true)EngageBondCounselResearchInd
Private Bus Use By Others0.0PrivateBusUseByOthersPct
Private Bus Concerning UBI0.0PrivateBusConcerningUBIPct
Total Private Business Use0.0TotalPrivateBusinessUsePct
Bond Iss Meet Prvt Sec Pymt TestfalseBondIssMeetPrvtSecPymtTestInd
Change In Use Bond Financed PropfalseChangeInUseBondFinancedPropInd
Procs Nonqualified Bond RemdtdYes (true)ProcsNonqualifiedBondRemdtdInd

Tax Exempt Bonds Arbitrage TaxExemptBondsArbitrageGrp

FieldValueIRS element (for citing)
Bond ReferenceABondReferenceCd
Form8038 T FiledfalseForm8038TFiledInd
Rebate Not Due YetfalseRebateNotDueYetInd
Exception To RebatefalseExceptionToRebateInd
No Rebate DueYes (true)NoRebateDueInd
Variable Rate IssuefalseVariableRateIssueInd
Hedge Identified In Bks And RecfalseHedgeIdentifiedInBksAndRecInd
Gross Proceeds Invested In GICfalseGrossProceedsInvestedInGICInd
Gross Proceeds InvestedfalseGrossProceedsInvestedInd
Written Proc To Monitor ReqsYes (true)WrittenProcToMonitorReqsInd

Procedures Corrective Action ProceduresCorrectiveActionGrp

FieldValueIRS element (for citing)
Bond ReferenceABondReferenceCd
Procedures Corrective ActionYes (true)ProceduresCorrectiveActionInd

Supplemental Information Detail SupplementalInformationDetail (2 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
Schedule K, Part I 07/13/2016 29535000 Oklahoma Industries AuthorityIn July 2016, the Foundation entered into advanced refinancing of the Series 2008 bonds. The Foundation issued $43,955,000 of OIA Series 2008 Revenue Bonds (the "Series 2008 Bonds") dated July 1, 2008; the proceeds from this bond were used to construct and equip a new research facility. The Series 2008 Bonds were defeased when the Foundation issued $29,535,000 of OIA Series 2016 Revenue Bonds (the "Series 2016 Bonds") dated July 13, 2016. The Series 2016 bonds mature on July 1, 2026 and bear interest at the stated rate of 1.81% per annum. Payments of principal and interest began January 1, 2017 and are due January 1st and July 1st of each year. The Series 2016 Bond agreements also require maintenance of a reserve fund which is included in investments in the accompanying statement of financial position. This amount was $2,953,500 as of June 30, 2022.
Schedule K, Part IV, Line 2c COLUMN AIssuer name: Oklahoma Industries Authority Revenue Bonds (OMRF Project) Series 2016 The calculation for computing no rebate due was performed on 07/01/2021

Schedule M IRS990ScheduleM

Securities Publicly Traded SecuritiesPubliclyTradedGrp

FieldValueIRS element (for citing)
Non Cash CheckboxYes (X)NonCashCheckboxInd
Contribution17ContributionCnt
Noncash Contributions Rpt F990$771,465NoncashContributionsRptF990Amt
Method Of Determining RevenuesMarket valueMethodOfDeterminingRevenuesTxt
FieldValueIRS element (for citing)
Form8283 Received0Form8283ReceivedCnt
Any Property That Must Be HeldfalseAnyPropertyThatMustBeHeldInd
Review Process Unusual NC GiftsYes (true)ReviewProcessUnusualNCGiftsInd
Third Parties UsedYes (true)ThirdPartiesUsedInd

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferenceSchedule M, Part I, Line 32b Third parties used to solicit, process, or sell noncash contributionsFormAndLineReferenceDesc
ExplanationThe Foundation contracts with a service organization who solicits the donation of vehicles. The service organization is responsible for communication with the donor as well as the selling process. The Foundation receives a check for 80% of the proceeds from the sale of the vehicle.ExplanationTxt

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (11 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
Form 990, Part III, Line 4d Description of other program services(Expenses $ 40,777,358 including grants of $ 0)(Revenue $ 30,570,204) Other program services include departments such as Cell Cycle and Cancer Biology, Genes and Human Disease, Genetic Models of Disease and other scientific and research support services.
Form 990, Part VI, Line 1a Delegate broad authority to a committeeThe Foundation's Board of Directors has delegated all of its powers to the Foundation's Executive Committee, except as follows: establish the overall policies and direction of the Foundation, appoint the members of the Executive Committee, elect and remove the Chair of the Board of Directors, amend the Bylaws and the Certificate of Incorporation of the Foundation, and appoint special committees to the Board of Directors. The Board of Directors may at any time amend or revoke this delegation of powers.
Form 990, Part VI, Line 11b Review of form 990 by governing bodyThe Form 990 is prepared by the Foundation, internally reviewed by the CFO. The Form 990-T is externally reviewed by the tax department of a public accounting firm. A summary of the Form 990 is presented for review to the Executive Committee. Subsequent to that review, the Form 990 with all supplemental schedules is made available to all members of the board of directors for review and comment prior to filing.
Form 990, Part VI, Line 12c Conflict of interest policyEach director, officer and key employee is annually provided with a copy of the Foundation's conflict of interest policy. Each of these individuals is annually provided with a questionnaire regarding potential conflicts and required to disclose any potential conflict that he or she might have. In addition, each of these individuals must annually sign a statement affirming that he or she has; received a copy of the conflicts of interest policy, read and understood the policy and agrees to comply with the policy. Once the Foundation has collected annual disclosure statements from all directors, officer and key employees, the Foundation's Governance Committee reviews such information to identify situations in which a potential conflict exists and is material. If a potential material conflict is identified, the committee analyzes whether the contemplated transaction may be authorized as just, fair, and reasonable to the Foundation. The Governance Committee then makes a recommendation to the Foundations' Executive Committee regarding the management of all potential conflicts it has identified. The final decision as to the approval and , where applicable, management of all such potential conflicts rests in the sole discretion of the Executive Committee, which makes such decisions based upon the welfare of the Foundation and the advancement of its purpose. The recommendations of the Governance Committee and decisions of the Executive Committee are documented in the respective minutes of these Committees' regular meetings.
Form 990, Part VI, Line 15a Process to establish compensation of top management officialCompensation for officers and key employees is determined and evaluated in May of each year by the executive committee of the board of directors based on comparability data from widely accepted peer bench marking salary surveys that are segmented by region and size of entity.
Form 990, Part VI, Line 15b Process to establish compensation of other employeesCompensation for officers and key employees is determined and evaluated in May of each year by the executive committee of the board of directors based on comparability data from widely accepted peer bench marking salary surveys that are segmented by region and size of entity.
Form 990, Part VI, Line 18 How forms are made available to the publicThe Foundation's Form 990 for the last three years are publicly available on the Foundation's website, as well as on Guidestar and other nonprofit databases. Form 1023, 990, and 990-T are provided upon request.
Form 990, Part VI, Line 19 Required documents available to the publicThe Foundation's governing documents, conflict of interest policy, and financial statements are provided upon request and are publicly available on the Foundation's website.
Form 990, Part XI, Line 9 Other changes in net assets or fund balancesCHANGES IN FAIR VALUE OF FUNDS HELD IN TRUST - -19063515; PENSION RELATED CHANGES OTHER THAN NET PERIODIC PENSION COSTS - 1403128;
Schedule F, Part I, Line 3Program service activity in all regions includes scientists attending and/or speaking at scientific conferences and collaborations. OMRF does not maintain ongoing operations in foreign jurisdictions however the Foundation's scientists do travel to various scientific conferences in other countries to share in scientific discoveries, as well as, to learn from other scientists across the world.
Form 990, Part VI Section A, Line 2The Foundation currently has 62 directors, many of whom are business leaders and members of prominent families in the State of Oklahoma. The Foundation believes there are multiple business relationships between and among board members and families of Board members, but the Foundation review of signed conflict of interest disclosures from all board members and of the Foundation's ledger accounts indicated there are no such relationships that would impair the fiduciary duties of any director to the Foundation.

Schedule R IRS990ScheduleR

Id Disregarded Entities IdDisregardedEntitiesGrp

Disregarded Entity Name DisregardedEntityName

FieldValueIRS element (for citing)
Business Name Line1Culbertson Plaza LLCBusinessNameLine1Txt

US Address USAddress

FieldValueIRS element (for citing)
Address Line1825 NE 13th StreetAddressLine1Txt
CityOklahoma CityCityNm
State AbbreviationOKStateAbbreviationCd
ZIP73104ZIPCd
FieldValueIRS element (for citing)
EIN842527142EIN
Primary ActivitiesManage real property known as the Culbertson Plaza Shopping CenterPrimaryActivitiesTxt
Legal Domicile StateOKLegalDomicileStateCd
Total Income$128,496TotalIncomeAmt
End Of Year Assets$1,426,413EndOfYearAssetsAmt

Direct Controlling Entity Name DirectControllingEntityName

FieldValueIRS element (for citing)
Business Name Line1Oklahoma Medical Research FoundationBusinessNameLine1Txt